| USD millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.1 | 0.5 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | (0.0) | (0.1) | (0.5) | (0.5) | 0.0 | 0.0 | — | |
| Research & development | 15.9 | 28.2 | 37.7 | 56.1 | 43.8 | 48.3 | +10.2% | |
| Selling, general & administrative | 3.6 | 11.6 | 16.1 | 25.8 | 10.6 | 14.7 | +38.7% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 19.6 | 39.8 | 53.8 | 83.1 | 54.4 | 63.0 | +15.7% | |
| Operating income | (19.6) | (39.8) | (53.8) | (83.1) | (54.4) | (63.0) | −15.7% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | (0.3) | (0.0) | +97.3% | |
| Interest income | 0.1 | 0.0 | 0.0 | 0.0 | 2.0 | 3.4 | +70.9% | |
| Other income / expense | 0.1 | 0.0 | 1.9 | 5.7 | 0.0 | 0.0 | — | |
| Pre-tax income | (19.5) | (39.8) | (52.0) | (77.4) | 0.0 | 0.0 | — | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (19.5) | (39.8) | (50.1) | (77.4) | 0.0 | 0.0 | — | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (0.80) | (2.19) | (2.04) | (2.30) | 0.00 | (4.40) | — | |
| EPS, diluted (per share) | (0.80) | (2.19) | (2.04) | (2.30) | 0.00 | (4.40) | — | |
| EBITDA | (19.5) | (39.8) | (53.8) | (82.2) | 0.7 | (63.0) | −9609.1% | |
| Depreciation & amortization | 0.0 | 0.1 | 0.5 | 0.2 | 0.7 | 0.8 | +25.4% | |
| Weighted average shares (shares) | 24,210,699 | 18,143,487 | 24,496,425 | 33,614,377 | 34,470,710 | 13,515,915 | −60.8% | |
| Weighted average diluted shares (shares) | 24,210,699 | 18,143,487 | 24,496,425 | 33,614,377 | 34,470,710 | 13,515,915 | −60.8% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
